retatrutide phase 3 trial dosing schedule dose schedule: complete week-by-week titration guide Retatrutide Dosing: Early Clinical Trial

Patients were excluded if they had a prescription fill within 60 days after the date of discontinuation or if the GLP-1 RA indication (AOM or ADM) could not be determined

Let symptoms settle before another meal

\Reduced Scarring: May decrease fibrosis and improve tissue architecture (Animal Study)

Metabolic Health Enhances fat burning and promotes a healthy metabolism

Compounded versions of semaglutide or tirzepatide are not the same as these FDA-approved products and have not undergone the same clinical trial processes

Large bubbles can affect dose accuracy-tap the barrel, push the bubble back into the vial, and re-draw to the correct mark